Skip to main content
Clinical Trials/NCT05015166
NCT05015166CompletedNot Applicable

Study of an Internet-delivered Treatment Based on Experiential Dynamic Psychotherapy for Social Anxiety Disorder

Stockholm University2 sites in 1 country181 target enrollmentStarted: August 18, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
181
Locations
2
Primary Endpoint
Liebowitz Social Anxiety Scale, Self-Report, (LSAS-SR)

Study Overview

Brief Summary

The aim of this randomized, controlled study is to examine an internet delivered, self-help program for social anxiety based on psychodynamic therapy. The study will compare three conditions: the psychodynamic program with therapist support, without therapist support and a waitlist control.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18 years old or older
  • Fulfill the DSM-5 criteria for social anxiety disorder (Score > 60 on the self-assessment instrument LSAS-SR)
  • Have access to a computer/smartphone/tablet with internet connection
  • Be able to read and write Swedish.

Exclusion Criteria

  • Suicidal (within the previous month, assessed with the self-assessment instrument C-SSRS)
  • Partaking in psychological treatment
  • Ongoing treatment with psychopharmacological drugs with dose adjustments within the nearest month or planned dose adjustments.
  • The following self-reported diagnoses are excluded:
  • Autism spectrum disorder
  • Serious depression (Score ≥ 20 on the PHQ9)
  • Indications of psychosis or bipolar disorder (type 1 or 2).

Outcomes

Primary Outcomes

Liebowitz Social Anxiety Scale, Self-Report, (LSAS-SR)

Time Frame: Change from baseline to post-treatment (8 week) and follow up (6, 12 and 24 months after treatment)

The LSAS-SR features 48 items assessing social anxiety symptoms.

Secondary Outcomes

  • Generalised Anxiety Disorder 7- item scale (GAD-7)(Change from baseline to post-treatment (8 week) and follow up (6, 12 and 24 months after treatment))
  • Patient Health Questionnaire 9-item scale (PHQ-9)(Change from baseline to post-treatment (8 week) and follow up (6, 12 and 24 months after treatment))
  • Brunnsviken Brief Quality of Life Scale (BBQ)(Change from baseline to post-treatment (8 week) and follow up (6, 12 and 24 months after treatment))

Investigators

Sponsor
Stockholm University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Per Carlbring

Professor

Stockholm University

Study Sites (2)

Loading locations...

Similar Trials